Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALV003 in well-controlled celiac disease
NCT00959114Phase 2Completed
- Sponsor
- Alvine Pharmaceuticals
- Start
- Aug 2009
- Primary completion
- Aug 2010
- Countries
- 1
01
Overview
A Phase 2 trial of latiglutenase in celiac disease, sponsored by Alvine Pharmaceuticals. Started Aug 2009; status: completed.
02
Drugs
latiglutenase
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT00959114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959114.